YildizIYildizPORencuzogullariI, et al.Association of serum osmolarity with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2019;70:627–32.
2.
BurgMBFerrarisJDDmitrievaNI. Cellular response to hyperosmotic stresses. Physiol Rev. 2007;87:1441–74.
3.
Arevalo-LoridoJCGomezJCFormigaF, et al.High serum osmolarity at admission determines a worse outcome in patients with heart failure: is a new target emerging?Int J Cardiol. 2016;221:238–42.
4.
UozumiYMizobeTMiyamotoH, et al.Decreased serum sodium levels predict symptomatic vasospasm in patients with subarachnoid hemorrhage. J Clin Neurosci. 2017;46:118–23.
5.
BihariSPrakashSPeakeSLBaileyMPilcherDBerstenA. ICU mortality is increased with high admission serum osmolarity in all patients other than those admitted with pulmonary diseases and hypoxia. Respirology. 2017;22:1165–70.
6.
KuwabaraMHisatomeIRoncal-JimenezCA, et al.Increased serum sodium and serum osmolarity are independent risk factors for developing chronic kidney disease; 5 year cohort study. PLoS One. 2017;12:e0169137.
7.
ShenYChengXYingMChangHTZhangW. Association between serum osmolarity and mortality in patients who are critically ill: a retrospective cohort study. BMJ Open. 2017;7:e015729.
8.
AzzaliniLVilcaLMLombardoF, et al.Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: comparison of five contrast media. Int J Cardiol. 2018;273:69–73.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Contrast-induced nephropathy: an “all or none” phenomenon?Angiology. 2015;66:508–13.
11.
BarbieriLVerdoiaMSchafferA, et al.Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study. Angiology. 2015;66:333–8.
12.
KurtulAMuratSNYarliogluesM, et al.Procalcitonin as an early predictor of contrast-induced acute kidney injury in patients with acute coronary syndromes who underwent percutaneous coronary intervention. Angiology. 2015;66:957–63.
13.
Jian-WeiZYu-JieZShu-JunCQingYShi-WeiYBinN. Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65:402–7.
14.
KurtulADuranMYarliogluesM, et al.Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Clin Cardiol. 2014;37:485–92.
15.
KurtulAYarliogluesMMuratSN, et al.Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Angiology. 2015;66:433–40.
16.
KayaAKayaYTopcuS, et al.Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65:51–6.
17.
SunXPLiJZhuWW, et al.Platelet to lymphocyte ratio predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2018;69:71–8.
18.
UlusTIsgandarovKYilmazAS, et al.Monocyte to high-density lipoprotein ratio predicts contrast-induced nephropathy in patients with acute coronary syndrome. Angiology. 2018;69:909–16.
19.
ErtasFAvciEKirisT. The ratio of fibrinogen to albumin as a predictor of contrast-induced nephropathy after carotid angiography. Angiology. 2019;70:458–64.
